Specifically, studies have shown that the administration of TGF-β to an in vitro HNSCC cell line (SCC9) induces the expression of a p-EMT program, while the inhibition of TGF-β reduces the expression of this program [21]. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.